Becton, Dickinson and Company Launches Enhanced Antimicrobial Stewardship Analytics Capabilities
November 21, 2019
November 21, 2019
FRANKLIN LAKES, New Jersey, Nov. 21 -- Becton, Dickinson and Co., a medical technology company, issued the following news release:
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced its latest advancement in combating antimicrobial resistance (AMR) with new analytics integrated into the company's connected medication management platform that identifies when an inappropriate and potentially ineffective antibiotic has been . . .
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced its latest advancement in combating antimicrobial resistance (AMR) with new analytics integrated into the company's connected medication management platform that identifies when an inappropriate and potentially ineffective antibiotic has been . . .